PubRank

Michael J Yost

Author PubWeight™ 30.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 2008 1.38
2 A three-dimensional model of vasculogenesis. Biomaterials 2008 1.09
3 Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 2009 1.07
4 Tissue engineering of skeletal muscle. Tissue Eng 2007 1.06
5 Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. J Cell Physiol 2004 1.00
6 Maxillofacial injuries and life-threatening hemorrhage: treatment with transcatheter arterial embolization. J Trauma 2003 0.99
7 Laparoscopic repair of large incisional hernias. Am Surg 2002 0.93
8 Epicardial development in the rat: a new perspective. Microsc Microanal 2006 0.93
9 Microtensile testing of collagen fibril for cardiovascular tissue engineering. J Biomed Mater Res A 2005 0.92
10 Fluid flow forces and rhoA regulate fibrous development of the atrioventricular valves. Dev Biol 2012 0.91
11 The connexin43 carboxyl-terminal peptide ACT1 modulates the biological response to silicone implants. Plast Reconstr Surg 2009 0.90
12 The influence of proepicardial cells on the osteogenic potential of marrow stromal cells in a three-dimensional tubular scaffold. Biomaterials 2008 0.89
13 Diabetes insipidus in the head-injured patient. Am Surg 2004 0.89
14 Adult reserve stem cells and their potential for tissue engineering. Cell Biochem Biophys 2004 0.88
15 An improved collagen scaffold for skeletal regeneration. J Biomed Mater Res A 2010 0.88
16 What is the future of diabetic wound care? Diabetes Educ 2006 0.86
17 A three-dimensional tubular scaffold that modulates the osteogenic and vasculogenic differentiation of rat bone marrow stromal cells. Tissue Eng Part A 2008 0.86
18 Mathematical modeling of flow-generated forces in an in vitro system of cardiac valve development. Ann Biomed Eng 2009 0.85
19 Use of a vacuum-assisted device to facilitate abdominal closure. Am Surg 2003 0.85
20 Coronary endothelial proliferation and morphogenesis are regulated by a VEGF-mediated pathway. Dev Dyn 2009 0.85
21 3D printing facilitated scaffold-free tissue unit fabrication. Biofabrication 2014 0.85
22 Scaffold-free tissue engineering: organization of the tissue cytoskeleton and its effects on tissue shape. Ann Biomed Eng 2014 0.84
23 Three-dimensional model system of valvulogenesis. Dev Dyn 2005 0.84
24 Biomedical implant capsule formation: lessons learned and the road ahead. Ann Plast Surg 2014 0.82
25 A 3-D cardiac muscle construct for exploring adult marrow stem cell based myocardial regeneration. Biomaterials 2010 0.81
26 Focused in vivo genetic analysis of implanted engineered myofascial constructs. J Invest Surg 2009 0.79
27 A 3-D model of coronary vessel development. In Vitro Cell Dev Biol Anim 2007 0.78
28 A model of tissue-engineered ventral hernia repair. J Invest Surg 2006 0.78
29 Effects of platelet-derived growth factor-AA and -BB on embryonic cardiac development. Anat Rec A Discov Mol Cell Evol Biol 2003 0.78
30 Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues. Tissue Eng Part B Rev 2014 0.78
31 Cocaine induced acidosis in the trauma patient: a potential confounding factor. Am Surg 2008 0.77
32 Massive ventral hernia with extensive heterotopic ossification: the honeycomb-abdomen. J Trauma 2009 0.77
33 Implanted scaffold-free prevascularized constructs promote tissue repair. Ann Plast Surg 2015 0.76
34 Clonogenic analysis reveals reserve stem cells in postnatal mammals. II. Pluripotent epiblastic-like stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004 0.76
35 Nanomechanical characterization of micro/nanofiber reinforced type I collagens. J Biomed Mater Res A 2007 0.76
36 Human satellite progenitor cells for use in myofascial repair: isolation and characterization. Ann Plast Surg 2010 0.76
37 Novel tissue engineered tubular heart tissue for in vitro pharmaceutical toxicity testing. Microsc Microanal 2007 0.75
38 The use of prognostic indicators in the development of a statistical model predictive for adrenal insufficiency in trauma patients. Am Surg 2007 0.75
39 Novel bacterial immobilization compound effectively decreases bacterial counts in healthy volunteers. Am Surg 2010 0.75
40 A biomechanical and morphologic analysis of capsule formation around implanted piezoelectric wafer active sensors in rats treated with cyclooxygenase-2 inhibition. Ann Plast Surg 2008 0.75
41 Unique recalcutrant hernia repair: enterocutaneous fistula with complex ventral hernia. Am Surg 2008 0.75
42 Cardiovascular tissue engineering I. Perfusion bioreactors: a review. J Long Term Eff Med Implants 2006 0.75